Sale and recall nationwide!Your family may also have

On August 29, the official website of the State Drug Administration issued a notice on 20 batches of medicines that did not meet the requirements, and Huoxiangzhengqi Water and Agarwa stagnation pills.

After inspection by 6 pharmaceutical inspection institutions including China Food and Drug Inspection Research Institute, 20 batches of drugs such as authentic medicine produced by 9 companies such as Zhengzhou Ruilong Pharmaceutical Co., Ltd. do not meet the regulations.

The list of 20 batches does not meet the requirements of the prescribed drugs as follows,

See if your medicine box is there?

(Click to view the big picture)

The relevant situation notice is as follows

● After inspection by the Food and Drug Quality Inspection and Research Institute of Food and Drug Quality in Fujian Province, the two batches of dihydroxolbacqurion -alkali injection produced by Shanxi Taiyuan Pharmaceutical Co., Ltd. (Yuan Taiyuan Pharmaceutical Factory) did not meet the regulations and did not meet the specified projects as visible foreign matter.

● After inspection by the Jilin Provincial Pharmaceutical Inspection and Research Institute, a batch of agarwood stagnation pills produced by Hebei Bianzhang Pharmaceutical Co., Ltd. did not meet the requirements, and did not meet the requirements of the specified project as the difference.

● After inspection by Jiangxi Pharmaceutical Inspection and Inspection and Research Institute, it is marked that the three batches of Huoxiang Zhengqi water produced by Sichuan Tianfu Kangda Pharmaceutical Group Mansion Group and Tai Chi Group Sichuan Nanchong Pharmaceutical Co., Ltd. do not meet the regulations and do not meet the regulations. For methanol.

● After being tested by the Guangdong Pharmaceutical Inspection Institute, a batch of Longze Bear Bald Capsules produced by Changchun Puhua Pharmaceutical Co., Ltd. did not meet the regulations, and did not meet the requirements of the specified project as a microbial limit.

● After inspection by the China Food and Drug Inspection Research Institute, the three batches of chrysanthemums produced by Yancheng Traditional Chinese Medicine Drinking Co., Ltd. do not meet the requirements, and do not meet the requirements of the regulations to disable pesticide residues.

● After being tested by the Gansu Provincial Academy of Pharmaceutical Inspection and Research, a batch of Qiancao produced by Yunnan Jian'antang Biotechnology Co., Ltd. does not meet the requirements, and does not meet the requirements of the specified projects, including traits and identification; The two batches of quotes produced do not meet the regulations, and do not meet the specified projects including traits, identification, total ash, acid and insoluble gray, and immersive.

● After inspection by the China Food and Drug Inspection Research Institute, a batch of purple grass produced by Guilin Zhongnan (Luzhou) Pharmaceutical Technology Co., Ltd. does not meet the regulations and does not meet the requirements of the specified project as the measurement. The six batches of purple grass produced do not meet the regulations and do not meet the specified projects as traits.

For the above -mentioned do not meet the prescribed drugs, the drug supervision and management department has requested relevant enterprises and units to take risk control measures such as suspension of sales, recall, and recall to conduct investigations and rectification on the reasons that do not meet the prescribed reasons.

The State Drug Administration requires relevant provincial drug supervision and management departments to investigate the cases of suspected illegal acts existing above in accordance with the "Pharmaceutical Management Law of the People's Republic of China", and publicize the results of the investigation and punishment in accordance with regulations.

Source: Shanxi Evening News All -Media Comprehensive

- END -